• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型多西紫杉醇壳聚糖包覆的 PLGA/PCL 纳米粒,具有增强的细胞毒性和生物利用度。

Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.

机构信息

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, P.O. Box 2457, Saudi Arabia; Department of Pharmaceutics, Faculty of Pharmacy, Al-Azhar University, Cairo, Egypt.

Department of Pharmaceutics, College of Pharmacy, King Saud University, Riyadh 11451, P.O. Box 2457, Saudi Arabia.

出版信息

Biomed Pharmacother. 2018 Oct;106:1461-1468. doi: 10.1016/j.biopha.2018.07.102. Epub 2018 Jul 24.

DOI:10.1016/j.biopha.2018.07.102
PMID:30119220
Abstract

In the present study, docetaxel (DTX)-loaded poly(lactic-co-glycolic acid) (PLGA) and polycaprolactone (PCL) nanoparticles were successfully prepared and coated with chitosan (CS). The prepared nanoparticles (NPs) were evaluated for their particle size, zeta potential, particle morphology, drug entrapment efficiency (EE%), and in vitro drug release profile. The anticancer activity of DTX-loaded NPs was assessed in human HT29 colon cancer cell line utilizing MTT assay. The pharmacokinetics of DTX-loaded NPs was monitored in Wistar rats in comparison to DTX solution. The prepared NPs exhibited particle sizes in the range 177.1 ± 8.2-287.6 ± 14.3 nm. CS decorated NPs exhibited a significant increase in particle size and a switch of zeta potential from negative to positive. In addition, high EE% values were obtained for CS coated PCL NPs and PLGA NPs as 67.1 and 76.2%, respectively. Moreover, lowering the rate of DTX in vitro release was achieved within 48 h by using CS coated NPs. Furthermore, a tremendous increase in DTX cytotoxicity was observed by CS-decorated PLGA NPs compared to all other NPs including DTX-free-NPs and pure DTX. The in vivo study revealed significant enhancement in DTX bioavailability from CS-decorated PLGA NPs with more than 4-fold increase in AUC compared to DTX solution. In conclusion, CS-decorated PLGA NPs are a considerable DTX-delivery carrier with magnificent antitumor efficacy.

摘要

在本研究中,成功制备了载多西紫杉醇(DTX)的聚乳酸-共-羟基乙酸(PLGA)和聚己内酯(PCL)纳米粒,并对其进行了壳聚糖(CS)包覆。对所制备的纳米粒(NPs)的粒径、Zeta 电位、颗粒形态、药物包封效率(EE%)和体外药物释放特性进行了评价。采用 MTT 法评估了载 DTX NPs 在人 HT29 结肠癌细胞系中的抗癌活性。并与 DTX 溶液相比,监测了载 DTX NPs 在 Wistar 大鼠体内的药代动力学。所制备的 NPs 的粒径在 177.1±8.2-287.6±14.3nm 范围内。CS 修饰的 NPs 的粒径显著增加,Zeta 电位从负变为正。此外,CS 涂覆的 PCL NPs 和 PLGA NPs 分别获得了高达 67.1%和 76.2%的高 EE%值。此外,通过使用 CS 涂覆的 NPs,可在 48h 内显著降低 DTX 的体外释放率。此外,与所有其他 NPs(包括无 DTX-NPs 和纯 DTX)相比,CS 修饰的 PLGA NPs 显著提高了 DTX 的细胞毒性。体内研究表明,与 DTX 溶液相比,CS 修饰的 PLGA NPs 显著提高了 DTX 的生物利用度,AUC 增加了 4 倍以上。总之,CS 修饰的 PLGA NPs 是一种有前途的 DTX 递送载体,具有优异的抗肿瘤疗效。

相似文献

1
Novel docetaxel chitosan-coated PLGA/PCL nanoparticles with magnified cytotoxicity and bioavailability.新型多西紫杉醇壳聚糖包覆的 PLGA/PCL 纳米粒,具有增强的细胞毒性和生物利用度。
Biomed Pharmacother. 2018 Oct;106:1461-1468. doi: 10.1016/j.biopha.2018.07.102. Epub 2018 Jul 24.
2
Preparation and characterization of surface-modified PLGA-polymeric nanoparticles used to target treatment of intestinal cancer.用于靶向治疗肠道癌症的表面修饰 PLGA 聚合物纳米颗粒的制备与表征。
Artif Cells Nanomed Biotechnol. 2018 Mar;46(2):432-446. doi: 10.1080/21691401.2017.1324466. Epub 2017 May 14.
3
Hyaluronic acid-decorated poly(lactic-co-glycolic acid) nanoparticles for combined delivery of docetaxel and tanespimycin.透明质酸修饰的聚(乳酸-共-乙醇酸)纳米粒用于多西他赛和坦西普尼的联合递送。
Carbohydr Polym. 2015 Jun 5;123:313-23. doi: 10.1016/j.carbpol.2015.01.064. Epub 2015 Feb 7.
4
Preparation and characterization of polymeric nanoparticles surface modified with chitosan for target treatment of colorectal cancer.用于结直肠癌靶向治疗的壳聚糖表面修饰聚合物纳米粒的制备与表征
Int J Biol Macromol. 2017 Feb;95:643-649. doi: 10.1016/j.ijbiomac.2016.11.098. Epub 2016 Nov 28.
5
The tumor-targeting core-shell structured DTX-loaded PLGA@Au nanoparticles for chemo-photothermal therapy and X-ray imaging.载多柔比星的靶向肿瘤核壳结构 PLGA@Au 纳米粒用于化疗-光热联合治疗及 X 射线成像。
J Control Release. 2015 Dec 28;220(Pt A):545-555. doi: 10.1016/j.jconrel.2015.11.016. Epub 2015 Nov 14.
6
Surface modification of PLGA nanoparticles with biotinylated chitosan for the sustained in vitro release and the enhanced cytotoxicity of epirubicin.用生物素化壳聚糖对聚乳酸-羟基乙酸共聚物纳米颗粒进行表面修饰,用于表柔比星的体外持续释放及增强细胞毒性。
Colloids Surf B Biointerfaces. 2016 Feb 1;138:1-9. doi: 10.1016/j.colsurfb.2015.11.033. Epub 2015 Nov 28.
7
Co-delivery of chemotherapeutic drugs with vitamin E TPGS by porous PLGA nanoparticles for enhanced chemotherapy against multi-drug resistance.载化疗药物和维生素 E TPGS 的多孔 PLGA 纳米粒共递送用于增强多药耐药性的化疗。
Biomaterials. 2014 Feb;35(7):2391-400. doi: 10.1016/j.biomaterials.2013.11.086. Epub 2013 Dec 19.
8
Co-administration with cell penetrating peptide enhances the oral bioavailability of docetaxel-loaded nanoparticles.与细胞穿透肽共同给药可提高载多西他赛纳米颗粒的口服生物利用度。
Drug Dev Ind Pharm. 2015 May;41(5):764-71. doi: 10.3109/03639045.2014.902465. Epub 2014 Mar 26.
9
Biodegradable nanoparticles sequentially decorated with Polyethyleneimine and Hyaluronan for the targeted delivery of docetaxel to airway cancer cells.依次用聚乙烯亚胺和透明质酸修饰的可生物降解纳米颗粒用于将多西他赛靶向递送至气道癌细胞。
J Nanobiotechnology. 2015 Apr 3;13:29. doi: 10.1186/s12951-015-0088-2.
10
Enhancing the in vitro anticancer activity of albendazole incorporated into chitosan-coated PLGA nanoparticles.将阿苯达唑包载入壳聚糖涂层的 PLGA 纳米粒中增强其体外抗癌活性。
Carbohydr Polym. 2017 Mar 1;159:39-47. doi: 10.1016/j.carbpol.2016.12.009. Epub 2016 Dec 7.

引用本文的文献

1
Peptide-Coated Polycaprolactone-Benzalkonium Chloride Nanocapsules for Targeted Drug Delivery to the Pancreatic β-Cell.肽涂层聚己内酯-苯扎氯铵纳米囊用于靶向胰腺β细胞的药物递送。
ACS Appl Bio Mater. 2024 Oct 21;7(10):6451-6466. doi: 10.1021/acsabm.4c00621. Epub 2024 Sep 24.
2
Autologous patient-derived exhausted nano T-cells exploit tumor immune evasion to engage an effective cancer therapy.自体患者来源耗竭纳米 T 细胞利用肿瘤免疫逃逸来实施有效的癌症治疗。
Mol Cancer. 2024 May 9;23(1):83. doi: 10.1186/s12943-024-01997-x.
3
Chitosan-Coated Azithromycin/Ciprofloxacin-Loaded Polycaprolactone Nanoparticles: A Characterization and Potency Study.
壳聚糖包衣的载阿奇霉素/环丙沙星聚己内酯纳米颗粒:表征与效能研究
Nanotechnol Sci Appl. 2023 Dec 21;16:59-72. doi: 10.2147/NSA.S438484. eCollection 2023.
4
Optimization of Bromocriptine-Mesylate-Loaded Polycaprolactone Nanoparticles Coated with Chitosan for Nose-to-Brain Delivery: In Vitro and In Vivo Studies.用于鼻脑递送的壳聚糖包被的载甲磺酸溴隐亭聚己内酯纳米粒的优化:体外和体内研究
Polymers (Basel). 2023 Sep 26;15(19):3890. doi: 10.3390/polym15193890.
5
Imiquimod-Loaded Chitosan-Decorated Di-Block and Tri-Block Polymeric Nanoparticles Loaded In Situ Gel for the Management of Cervical Cancer.负载咪喹莫特的壳聚糖修饰二嵌段和三嵌段聚合物纳米颗粒原位凝胶用于宫颈癌治疗
Gels. 2023 Sep 3;9(9):713. doi: 10.3390/gels9090713.
6
A novel intra-tumoral drug delivery carrier for treatment of oral squamous cell carcinoma.一种新型肿瘤内药物递送载体,用于治疗口腔鳞状细胞癌。
Sci Rep. 2023 Jul 25;13(1):11984. doi: 10.1038/s41598-023-38230-6.
7
Amelioration of Cancer Employing Chitosan, Its Derivatives, and Chitosan-Based Nanoparticles: Recent Updates.利用壳聚糖及其衍生物和基于壳聚糖的纳米颗粒改善癌症:最新进展
Polymers (Basel). 2023 Jul 1;15(13):2928. doi: 10.3390/polym15132928.
8
Synergistic cytotoxicity effect of the combination of chitosan nanoencapsulated imatinib mesylate and quercetin in BCR-ABL positive K562 cells.壳聚糖纳米包封甲磺酸伊马替尼与槲皮素联合应用对BCR-ABL阳性K562细胞的协同细胞毒性作用
Iran J Basic Med Sci. 2023 Mar;26(3):359-366. doi: 10.22038/IJBMS.2023.68472.14934.
9
Essential Oils Extracted from Oleo Gum Resin Loaded into PLGA-PCL Nanoparticles: Enhanced Cytotoxic and Apoptotic Effects against Breast Cancer Cells.负载于聚乳酸-羟基乙酸共聚物-聚己内酯纳米颗粒中的油胶树脂提取的精油:增强对乳腺癌细胞的细胞毒性和凋亡作用
ACS Omega. 2022 Dec 19;8(1):1017-1025. doi: 10.1021/acsomega.2c06390. eCollection 2023 Jan 10.
10
RGD_PLGA Nanoparticles with Docetaxel: A Route for Improving Drug Efficiency and Reducing Toxicity in Breast Cancer Treatment.载多西他赛的RGD-聚乳酸-羟基乙酸共聚物纳米粒:提高乳腺癌治疗药物疗效并降低毒性的途径
Cancers (Basel). 2022 Dec 20;15(1):8. doi: 10.3390/cancers15010008.